University · founded 1789
University of North Carolina at Chapel Hill
Chapel Hill, United States · unc.edu
- Citations, last 5 years
- 571.2k
- Works, last 5 years
- 93.1k
- h-index
- 1,675
- Scientists listed
- 9 724
- Grants since 2016
- 10.8k
Grants received
2012–2024 · cooperative agreement · U19
Systems Immunogenetics and Bioinformatics
Shannon K. Mcweeney · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2012–2024 · cooperative agreement · U19
Systems Immunogenetics of Flavivirus infection in the Collaborative Cross
Michael Gale · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2012–2024 · cooperative agreement · U19
Administrative Core
Ralph S Baric · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2012–2024 · cooperative agreement · U19
Systems Immunogenetics of Emerging Coronavirus Infections in the Collaborative Cross
Ralph S Baric · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2012–2024 · cooperative agreement · U19
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross
Mark T Heise · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Colitis, Colon Cancer and the NLR Family
Jenny P Ting · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · cooperative agreement · U01
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
Jonathan S Berg · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2027 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2020 · research · R01
Catalytic Enantioselective Cation Radical-Mediated Transformations
David A Nicewicz · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2028 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Catalytic Enantioselective Cation Radical-Mediated Transformations
David A Nicewicz · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation Supplement
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Colitis, Colon Cancer and the NLR Family
Jenny P Ting · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · cooperative agreement · U01
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
Jonathan S Berg · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2023 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Micro-RNA 122 and Chronic Hepatitis C
Stanley M. Lemon · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Micro-RNA 122 and Chronic Hepatitis C
Stanley M. Lemon · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2027 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · research · R01
Genetic epidemiology of rare and regulatory variants for metabolic traits
Karen L. Mohlke · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Daniel K. Benjamin · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2027 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2026 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2026 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
Blossom A Damania · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Micro-RNA 122 and Chronic Hepatitis C
Stanley M. Lemon · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2026 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · cooperative agreement · U01
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
Jonathan S Berg · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2022 · cooperative agreement · U01
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
Jonathan S Berg · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Daniel K. Benjamin · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2026 · training · T32
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Kim L.R. Brouwer · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Micro-RNA 122 and Chronic Hepatitis C
Stanley M. Lemon · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · research · R01
Micro-RNA 122 and Chronic Hepatitis C
Stanley M. Lemon · University of North Carolina at Chapel Hill · funded by National Institutes of Health
2011–2021 · cooperative agreement · U01
North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing 2
Jonathan S Berg · University of North Carolina at Chapel Hill · funded by National Institutes of Health
